AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Oragenics Inc.
XASE · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SL28N5
0.42▲ 0.01 (2.90%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
0.41
Day's Range
0.40 – 0.42
52-Week Range
0.40 – 1.34
Volume
9,079
Avg Volume
26.1K
Share Statistics
Shares Outstanding
Employees
3
Exchange
XASE
Listed
2003-07-03
Share count as of August 12, 2026

Oragenics Inc. (OGEN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Oragenics Inc. (OGEN)
What is Oragenics Inc.'s Market Cap?
Oragenics Inc.'s Market Cap is $1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Oragenics Inc.'s Enterprise Value?
Oragenics Inc.'s Enterprise Value is -$2.0M, based on as-reported figures from SEC (XBRL) filings.
What is Oragenics Inc.'s Net Income (TTM)?
Oragenics Inc.'s Net Income (TTM) is -$10.1M, based on as-reported figures from SEC (XBRL) filings.
What is Oragenics Inc.'s Diluted EPS (TTM)?
Oragenics Inc.'s Diluted EPS (TTM) is -2.23, based on as-reported figures from SEC (XBRL) filings.
What is Oragenics Inc.'s Net Debt?
Oragenics Inc.'s Net Debt is -$3.9M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · OGENAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Total operating expenses
Loss from operations
Other income (expense):
Interest and Dividend Income (Non-Bank)
Interest expense
Foreign Currency Gain/Loss
Total other (expense) income, net
Income Before Tax——
Income tax (expense) benefit——
Net loss
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—